Unity Biotechnology’s (UBX) Buy Rating Reiterated at HC Wainwright
Unity Biotechnology (NASDAQ:UBX – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. They presently have a $4.00 price objective on the stock. HC Wainwright’s price objective points to a potential upside of 306.63% from the company’s […]
